FIELD: medicine.
SUBSTANCE: laser retina coagulation is carried out in the form of subthreshold "focal lattice" in combination with medication, comprising administration of 0.3-0.5 ml of dalargin under the conjunctiva or parabulbarly for 5-10 days after laser coagulation. Additional administration of 0.3-0.5 ml of dalargin under the conjunctiva or parabulbarly is performed for 5-10 days prior to laser coagulation. Vessel Due F 600 LE is also introduced intramusculary for 10 days prior to laser coagulation and Vessel Due F 250 LE or Sulodexide 250 LE is administered orally 2 times a day for 30 days after laser coagulation.
EFFECT: method allows to increase the efficiency of macular edema treatment for patients with retinal vascular disease.
17 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING OPHTHALMIC DISEASES | 1999 |
|
RU2198641C2 |
| COMBINED METHOD FOR TREATING CHOROIDAL NEOVASCULATION OF ALL TYPES | 2021 |
|
RU2770745C1 |
| METHOD OF TREATING AN ILZE'S DISEASE | 2018 |
|
RU2696045C1 |
| METHOD FOR CYSTIC MACULAR EDEMA LASER TREATMENT | 2016 |
|
RU2622378C1 |
| METHOD FOR COMPREHENSIVE TREATMENT OF MACULAR EDEMA ASSOCIATED WITH OCCLUSION OF BRANCH OF CENTRAL RETINAL VEIN WITH OCT CONTROL IN REAL TIME | 2019 |
|
RU2749122C1 |
| METHOD OF TREATMENT OF MORPHOFUNCTIONAL DISTURBANCE OF CENTRAL ZONE OF RETINA FOLLOWING VITREORETINAL SURGERY OF RETINAL DETACHMENT | 2008 |
|
RU2381774C1 |
| METHOD FOR PREVENTING THE DEVELOPMENT OF DIABETIC MACULAR EDEMA IN PATIENTS AT TYPE II DIABETES | 2006 |
|
RU2314072C1 |
| COMPLEX METHOD OF MACULAR OEDEMA TREATMENT IN RETINAL VEIN OCCLUSIONS | 2019 |
|
RU2718847C1 |
| METHOD FOR TREATMENT OF MACULAR EDEMA OF RETINA | 2016 |
|
RU2635530C1 |
| METHOD OF TREATING OCCLUSION OF CENTRAL VEIN OF RETINA AND ITS BRANCHES | 2015 |
|
RU2603318C1 |
